NLRP3 inflammasome activation in the placenta during SARS-CoV-2 infection
Placenta · 2026
DOI: 10.1016/j.placenta.2025.12.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Placenta, 2026. Verfasst von Ana María Arboleda-Borrero und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nutrition Group, Department of Physiological Sciences, Faculty of Health, Universidad Del Valle, Colombia. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Placenta, COVID-19, Inflammasomes. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Non-US Government Research Support type, Universidad del Valle.
Abstract (Originalsprache)
BACKGROUND: The NLRP3 inflammasome is a key regulator of innate immunity. Its overactivation contributes to cytokine release and tissue inflammation during SARS-CoV-2 infection. However, its role in placental inflammation and pregnancy outcomes remains unclear. OBJECTIVE: To evaluate whether SARS-CoV-2 infection during pregnancy induces NLRP3 inflammasome activation in placental tissue and to assess its association with maternal and neonatal outcomes. METHODS: A prospective cohort study included 25 pregnant women with RT-PCR-confirmed COVID-19 and 25 healthy controls. Placental NLRP3, Caspase-1, IL-1β, and IL-18 expression were analyzed by qRT-PCR and Western blotting. Maternal and cord plasma cytokines were quantified by ELISA and cytometric bead array. Viral RNA, antibody transfer, and nutrient transporter gene expression were also evaluated. RESULTS: Placentas from infected women showed higher NLRP3 (p = 0.015) and Caspase-1 (p = 0.029) mRNA levels compared with controls. Western blotting detected procaspase-1 (∼50 kDa) and cleaved caspase-1 (∼35 kDa), indicating inflammasome activation. Maternal IL-18 concentrations were elevated (p = 0.013), while IL-1β remained unchanged. SARS-CoV-2 RNA was identified in 8 % of placentas (variants 21H and 20A). IgG antibodies were found in 28 % of maternal and 24 % of cord samples (p = 0.017). Infected pregnancies showed lower gestational age at delivery (p = 0.023), higher cesarean rate (p = 0.004), and lower neonatal Apgar scores (p = 0.006, p = 0.015). Nutrient transporter expression was preserved. CONCLUSION: SARS-CoV-2 infection during pregnancy induces activation of the NLRP3 inflammasome in placental tissue and systemic elevation of IL-18, indicating both local and systemic inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nutrition Group, Department of Physiological Sciences, Faculty of Health, Universidad Del Valle, Colombia.
- Grupo MUGER, Department of Gynecology and Obstetrics, Universidad Del Valle, Colombia; Section of Gynecology and Obstetrics, Hospital Universitario Del Valle, Colombia.
- Grupo MACOS, Department of Morphology, Faculty of Health, Universidad Del Valle, Colombia; Section of Gynecology and Obstetrics, Hospital Universitario Del Valle, Colombia.
- Nutrition Group, Department of Physiological Sciences, Faculty of Health, Universidad Del Valle, Colombia. Electronic address: mildrey.mosquera@correounivalle.edu.co.
Förderung
- Non-US Government Research Support type
- Universidad del Valle
Zitieren
APA
Arboleda-Borrero, A. M., Jiménez-Charris, E., Gómez, L. A., Saldarriaga, W., Fonseca, J., & Mosquera Escudero, M. (2026). NLRP3 inflammasome activation in the placenta during SARS-CoV-2 infection. Placenta. https://doi.org/10.1016/j.placenta.2025.12.007
Vancouver
Arboleda-Borrero AM, Jiménez-Charris E, Gómez LA, Saldarriaga W, Fonseca J, Mosquera Escudero M. NLRP3 inflammasome activation in the placenta during SARS-CoV-2 infection. Placenta. 2026. doi:10.1016/j.placenta.2025.12.007
BibTeX
@article{ArboledaBorrero2026,
author = {Arboleda-Borrero, Ana María and Jiménez-Charris, Eliécer and Gómez, Laura Andrea and Saldarriaga, Wilmar and Fonseca, Javier and Mosquera Escudero, Mildrey},
title = {NLRP3 inflammasome activation in the placenta during SARS-CoV-2 infection},
journal = {Placenta},
year = {2026},
doi = {10.1016/j.placenta.2025.12.007}
}
EUVIMED